A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes
Public ClinicalTrials.gov record NCT02097277. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of BMS-986036 in Obese Adults With Type-2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the potential of BMS-986036 for treatment obese adults with type-2 diabetes.
Study identification
- NCT ID
- NCT02097277
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 219 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 14, 2014
- Primary completion
- Sep 21, 2015
- Completion
- May 16, 2016
- Last update posted
- Jul 30, 2019
2014 – 2016
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Clinical Research | Little Rock | Arkansas | 72205 | — |
| Anaheim Clinical Trials Llc | Anaheim | California | 92801 | — |
| National Research Institute | Los Angeles | California | 90057 | — |
| Encompass Clinical Research | Spring Valley | California | 91978-1522 | — |
| Encompass Clinical Research | Spring Valley | California | 91978 | — |
| All Medical Research, Llc | Cooper City | Florida | 33024 | — |
| Central Kentucky Research Associates, Inc. | Lexington | Kentucky | 40509 | — |
| Premier Research | Trenton | New Jersey | 08611 | — |
| Metrolina Internal Medicine | Charlotte | North Carolina | 28204 | — |
| Sterling Research Grp, Ltd. | Cincinnati | Ohio | 45219 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02097277, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 30, 2019 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02097277 live on ClinicalTrials.gov.